Quantcast

Latest Metformin Stories

2014-04-08 08:30:26

--MBT Previously Reported Statistically Significant Positive Topline Results from this First Double-Blind, Randomized Clinical Trial of a Microbiome Modulator for Diabetes-- BROOMFIELD, Colo., April 8, 2014 /PRNewswire/ -- MicroBiome Therapeutics(TM) LLC, (MBT) today announced that data from the company's clinical trial of microbiome modulator NM504 in development for type 2 diabetes and prediabetes has been accepted for a Poster Preview Presentation at ICE/ENDO 2014, the joint...

2014-03-27 08:34:15

Sub-analyses Investigate the Effects of alogliptin on Cardiovascular Mortality Rates and Hospitalization for Heart Failure in Type 2 Diabetes Patients with Recent Acute Coronary Syndrome WASHINGTON and OSAKA, Japan, March 27, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) will present sub-analyses from the global EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome)...

2014-03-26 08:28:48

DUBLIN, Mar. 26, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/5bf97k/research_report ) has announced the addition of the "Concise Analysis of the Chinese Antidiabetic Drug Market" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) As China's society is further aging and obesity caused by improved living level and unhealthy lifestyle is increasing, the prevention and cure to diabetes become more difficult. The...

2014-03-06 23:28:29

Diabetic Patients Can Obtain Discounts of 10%-75% on Lantus and Metformin San Antonio, TX (PRWEB) March 06, 2014 As of 2013, diabetes affected nearly 26 million people—more than 8% of the U.S. population. This number includes those diagnosed with "pre-diabetes" as well as those who manage their condition with diet and exercise, oral medication, or by injecting insulin. Diabetes is a serious condition, and improper management can lead to blindness, limb atrophy and...

2014-02-18 08:30:35

--Statistically Significant Positive Results from First Double-Blind, Randomized Clinical Trial of a Microbiome Modulator for Diabetes-- BROOMFIELD, Colo., Feb. 18, 2014 /PRNewswire/ -- MicroBiome Therapeutics(TM)( )LLC, (MBT) today announced positive top-line results from the company's clinical trial of lead microbiome modulator NM504 in development for type 2 diabetes and prediabetes. NM504 is designed to improve glucose tolerance and other metabolic parameters in patients with...

2014-02-14 23:20:53

Researchers say the diabetes drug does not appear to reduce the risk of bladder cancer in patients with type 2 diabetes. Raleigh, NC (PRWEB) February 14, 2014 New research conducted at the University of Pennsylvania’s Abramson Cancer Center and reported by Cancer Monthly finds that patients on the popular type 2 diabetes drug metformin (Glucophage) have about the same risk of getting bladder cancer as patients on another class of drugs called sulfonylureas . Both types of drugs carry a...

Chinese Medicine Prevents Diabetes
2014-01-17 11:20:46

Brett Smith for redOrbit.com - Your Universe Online Traditional Chinese medicine has been around for thousands of years, and a new study in the Journal of Clinical Endocrinology & Metabolism has found that a mixture of 10 Chinese herbal medicines called Tianqi may help stall the progression from a pre-diabetes condition to a formal diabetes diagnosis. Patients are considered to have pre-diabetes when they develop elevated blood sugar levels, but not to the point of those with type-2...

2014-01-13 16:25:24

CINCINNATI, Jan. 13, 2014 /PRNewswire-USNewswire/ -- The diabetes drug metformin is also being tested in numerous clinical trials for treating different cancers, and several studies point to its apparent activation of a molecular regulator of cell metabolism called AMPK to suppress tumor growth. (Logo: http://photos.prnewswire.com/prnh/20110406/MM79025LOGO) But new research appearing the week of Jan. 13 in Proceedings of the National Academy of Sciences (PNAS) suggests that...

2014-01-10 23:19:58

ResearchMoz.us include new market research report "Research Report on China Antidiabetic Drug Market, 2014-2018" to its huge collection of research reports. Full Report With TOC @ http://www.researchmoz.us/research-report-on-china-antidiabetic-drug-market-2014-2018-report.html. Albany, NewYork (PRWEB) January 10, 2014 In 2013, the diabetes prevalence rate of grown-ups aged in 20 to 79 was 8.3% in the globe. The number of sufferers reached 382 million. 80% of the patients lives...

FDA Approves Novel AstraZeneca, Bristol-Meyers Squibb Diabetes Drug
2014-01-10 11:37:58

Ranjini Raghunath for redOrbit.com - Your Universe Online The FDA has approved the use of a new Type 2 diabetes drug called Farxiga, developed by pharmaceutical companies Bristol-Meyers Squibb and AstraZeneca. Type 2 diabetes affects 24 million people in the US and nearly 350 million people worldwide. Conventional diabetes drugs work by reducing the amount of sugar the body absorbs from food or by boosting the production of insulin which disposes of excess sugar. Farxiga, however,...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related